<code id='780B3544CF'></code><style id='780B3544CF'></style>
    • <acronym id='780B3544CF'></acronym>
      <center id='780B3544CF'><center id='780B3544CF'><tfoot id='780B3544CF'></tfoot></center><abbr id='780B3544CF'><dir id='780B3544CF'><tfoot id='780B3544CF'></tfoot><noframes id='780B3544CF'>

    • <optgroup id='780B3544CF'><strike id='780B3544CF'><sup id='780B3544CF'></sup></strike><code id='780B3544CF'></code></optgroup>
        1. <b id='780B3544CF'><label id='780B3544CF'><select id='780B3544CF'><dt id='780B3544CF'><span id='780B3544CF'></span></dt></select></label></b><u id='780B3544CF'></u>
          <i id='780B3544CF'><strike id='780B3544CF'><tt id='780B3544CF'><pre id='780B3544CF'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:896
          Cathy McMorris Rodgers -- health policy coverage from STAT
          Rep. Cathy McMorris Rodgers announced her plans to leave Congress at the end of 2024. Anna Moneymaker/Getty Images

          WASHINGTON — Rep. Cathy McMorris Rodgers, the chair of a crucial House committee that handles health care issues, plans to leave Congress at the end of the year, she announced Thursday.

          It will be a major shakeup for a panel already ravaged by Republican retirements. Reps. Michael Burgess (R-Texas), Larry Bucshon (R-Ind.), Jeff Duncan (R-S.C.), Debbie Lesko (R-Ariz.), Greg Pence (R-Ind.) and Kelly Armstrong (R-N.D.) are all leaving at the end of this Congress, too.

          advertisement

          Under McMorris Rodgers, the panel led the way for House passage of a health care price transparency package that included the first major proposal to equalize payment between hospital outpatient departments and physician offices.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)
          The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Venture capitalist Bob Kocher on the state of digital health

          BobKocher,apartneratventurecapitalfirmVenrock,speakingatSTAT'sBreakthroughSummitinSanFrancisco.Sarah